Suppr超能文献

死后生物体液中存在γ-羟基丁酸(GHB)的进一步证据:对研究结果解释的启示

Further evidence for the presence of GHB in postmortem biological fluid: implications for the interpretation of findings.

作者信息

Elliott Simon P

机构信息

Regional Laboratory for Toxicology, City Hospital N.H.S. Trust, Dudley Road, Birmingham B18 7QH, United Kingdom.

出版信息

J Anal Toxicol. 2004 Jan-Feb;28(1):20-6. doi: 10.1093/jat/28.1.20.

Abstract

Analysis and interpretation of the findings for the drug of abuse gamma hydroxybutyric acid (GHB) in fatalities has become very problematic. This is primarily because of variable data in postmortem biological fluids resulting from the endogenous nature of the compound, possible postmortem production, and varying methods of detection. Preliminary studies support the use of plasma standards in determining urinary GHB concentrations and indicate measurement of GHB in postmortem biological fluids may be dependent on the method of analysis. In order to assist interpretation of postmortem data based on gas chromatography-mass spectrometry (GC-MS) analysis using GHB-d6 internal standard, the results of GHB concentrations measured routinely in postmortem blood and urine specimens in 40 fatalities received during a three-month period are shown. In all cases, GHB was not implicated in the cause of death; there was no apparent correlation between manner of death and resultant GHB concentrations. Mean concentrations of GHB determined in postmortem blood were found to be 12.3 mg/L (range = 2-29 mg/L, n = 38) and 12.6 mg/L (range = 4-25 mg/L, n = 17) (unpreserved and sodium fluoride-preserved samples, respectively) and 5.5 mg/L in unpreserved urine (range 0-18 mg/L, n = 39) and 4.8 mg/L in sodium fluoride-preserved (range 0-10 mg/L, n = 15) urine samples. Vitreous humor was available in two of the cases analyzed (GHB = 1 and 3 mg/L). The data support the potential use of sodium fluoride-preserved samples for interpretation of GHB concentrations, particularly if there has been an extended postmortem interval. In addition, interpretative cut-offs can be proposed for both postmortem blood and urine, based on the specific GC-MS method used. At blood concentrations less than 30 mg/L and at urine concentrations less than 20 mg/L, it is possible that any GHB detected could represent only endogenous GHB production.

摘要

对滥用药物γ-羟基丁酸(GHB)在死亡案例中的调查结果进行分析和解读已变得非常棘手。这主要是由于该化合物的内源性、死后可能产生的情况以及不同的检测方法,导致死后生物体液中的数据存在差异。初步研究支持使用血浆标准来确定尿液中GHB的浓度,并表明死后生物体液中GHB的测量可能取决于分析方法。为了辅助基于使用GHB-d6内标物的气相色谱-质谱联用(GC-MS)分析来解读死后数据,展示了在三个月期间接收的40例死亡案例中,常规测量的死后血液和尿液标本中GHB浓度的结果。在所有案例中,GHB均未被认为是死因;死亡方式与最终的GHB浓度之间没有明显关联。发现死后血液中GHB的平均浓度分别为12.3毫克/升(范围 = 2 - 29毫克/升,n = 38)和12.6毫克/升(范围 = 4 - 25毫克/升,n = 17)(分别为未保存和氟化钠保存的样本),未保存尿液中的浓度为5.5毫克/升(范围0 - 18毫克/升,n = 39),氟化钠保存尿液样本中的浓度为4.8毫克/升(范围0 - 10毫克/升,n = 15)。在分析的两个案例中可获得玻璃体液(GHB = 1和3毫克/升)。这些数据支持使用氟化钠保存的样本解读GHB浓度的可能性,特别是在死后间隔时间较长的情况下。此外,基于所使用的特定GC-MS方法,可以为死后血液和尿液提出解释性临界值。当血液浓度低于30毫克/升且尿液浓度低于20毫克/升时,检测到的任何GHB可能仅代表内源性GHB的产生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验